BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24687052)

  • 1. Schizophrenia drug gets negative results for negative symptoms.
    Kingwell K
    Nat Rev Drug Discov; 2014 Apr; 13(4):244-5. PubMed ID: 24687052
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutics: Negative feedback.
    Dolgin E
    Nature; 2014 Apr; 508(7494):S10-1. PubMed ID: 24695327
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.
    Umbricht D; Alberati D; Martin-Facklam M; Borroni E; Youssef EA; Ostland M; Wallace TL; Knoflach F; Dorflinger E; Wettstein JG; Bausch A; Garibaldi G; Santarelli L
    JAMA Psychiatry; 2014 Jun; 71(6):637-46. PubMed ID: 24696094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bitopertin: the good news and bad news.
    Goff DC
    JAMA Psychiatry; 2014 Jun; 71(6):621-2. PubMed ID: 24696065
    [No Abstract]   [Full Text] [Related]  

  • 5. ACS chemical neuroscience molecule spotlight on RG1678.
    Hopkins CR
    ACS Chem Neurosci; 2011 Dec; 2(12):685-6. PubMed ID: 22860161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia?
    Chue PS; Baker GB
    Future Med Chem; 2013 Sep; 5(13):1475-7. PubMed ID: 24024940
    [No Abstract]   [Full Text] [Related]  

  • 7. Glycine Transporter Type I (GlyT1) Inhibitor, Bitopertin: A Journey from Lab to Patient.
    Pinard E; Borroni E; Koerner A; Umbricht D; Alberati D
    Chimia (Aarau); 2018 Aug; 72(7):477-484. PubMed ID: 30158010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia.
    Kaushik GN
    Psychopharmacology (Berl); 2011 May; 215(2):401; author reply 399. PubMed ID: 21193982
    [No Abstract]   [Full Text] [Related]  

  • 9. DU-127090 Solvay/H Lundbeck.
    Wolf W
    Curr Opin Investig Drugs; 2003 Jan; 4(1):72-6. PubMed ID: 12625033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
    MMW Fortschr Med; 2002 May; Suppl 2():89. PubMed ID: 12070872
    [No Abstract]   [Full Text] [Related]  

  • 11. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K; Tungaraza TE; Harborne GC
    J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia.
    Sumiyoshi T; Higuchi Y; Matsui M; Arai H; Takamiya C; Meltzer HY; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):965-7. PubMed ID: 17391821
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
    Nurowska K; Welbel L
    Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
    [No Abstract]   [Full Text] [Related]  

  • 14. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
    Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of schizophrenia negative symptoms: future prospects.
    Erhart SM; Marder SR; Carpenter WT
    Schizophr Bull; 2006 Apr; 32(2):234-7. PubMed ID: 16492797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combining effectiveness and tolerance].
    Krankenpfl J; 2005; 43(1-3):26-7. PubMed ID: 15912821
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of aripiprazole in treating obsessive compulsive symptoms.
    Yang KC; Su TP; Chou YH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):585-6. PubMed ID: 18037548
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.